Bharat Biotech

India’s first intra-nasal Corona vaccine: GK & Current Affairs Facts

The country’s first intranasal COVID vaccine iNCOVACC by Bharat Biotech has recently received DCGI approval for primary immunization against the infection for people above the age of 18 years. This vaccine has been named ChAd36-SARS-CoV-S COVID-19. Highlights ChAd36-SARS-CoV-S COVID-19 (Chimpanzee ..

Month: 

Category: 

Bharat Biotech’s intranasal vaccine – Update

Bharat Biotech recently sought approval for its intranasal Covid vaccine candidate, BBV154, as two-dose vaccine as well as booster dose. It submitted data from Phase 3 clinical trials of BBV154 to seek approval. Highlights: The heterologous booster infers that, third or ..

Month: 

Category: 

EUA to Corbevax for 12-18 Age Group

A vaccine manufacturer based in Hyderabad, Biological E has received emergency use authorization (EUA) from the drug regulator of India for its Covid-19 vaccine for children aged 12 to 18. Overview: Biological E’s Corbevax vaccine was earlier approved by the ..

Month: 

Category: 

Bharat Biotech Nasal Booster Trials

The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are being introduced for the vulnerable population. The booster doses will provide the ..

Month: 

Category: 

Conditional market approval for Covaxin, Covishield

The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional ..

Month: 

Category: 

Padma Awards 2022

The Padma Awards 2022 is to be conferred to vaccine makers to semiconductor market rulers. This time, the Padma awards are being presented to a diversified list of recipients. Around 128 people are to receive the award in 2022. The ..

Month: 

Category: